行情

ZSAN

ZSAN

Zosano Pharma
NASDAQ

实时行情|Nasdaq Last Sale

1.950
+0.040
+2.09%
已收盘, 16:00 10/17 EDT
开盘
1.940
昨收
1.910
最高
2.070
最低
1.884
成交量
38.79万
成交额
--
52周最高
6.65
52周最低
1.410
市值
2,627.32万
市盈率(TTM)
-0.6794
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ZSAN 新闻

  • 菲律宾拟对电子烟大幅加税
  • 新浪财经.1小时前
  • 沙特阿美:IPO时机将取决于市场条件和股东
  • 新浪财经.2小时前
  • 如何投资红利ETF:耐心比择时更重要么?
  • 新浪财经.2小时前
  • 易纲会见美联储主席鲍威尔 交换了对货币政策等看法
  • 央行.2小时前

更多

所属板块

生物技术和医学研究
+0.95%
制药与医学研究
+0.61%

热门股票

名称
价格
涨跌幅

ZSAN 简况

Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability. The Company's short-wear-time transdermal patch consists of an array of titanium microneedles that is coated with its formulation of an approved drug and attached to an adhesive patch. When the patch is applied with its hand-held applicator, the microneedles painlessly penetrate the skin, resulting in rapid dissolution and absorption of the drug coating through the capillary bed. Its product candidates include ZP-Triptan, ZP-Glucagon and ZP-PTH. ZP-PTH is a formulation of teriparatide, a synthetic form of parathyroid hormone. ZP-Glucagon is a formulation of glucagon.
展开

Webull提供Zosano Pharma Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。